Fischer Medical Ventures Ltd — Board Meeting, 28-07-2025: Board Meeting

Fischer Medical Ventures' board has approved a significant 1-for-10 share sub-division. Each existing equity share with a face value of ₹10 will be split into ten shares of ₹1 face value. This strategic decision aims to make the shares more affordable and attractive to retail investors, thereby enhancing the company's stock liquidity in the market. The authorized share capital remains ₹80 Cr, and the paid-up capital ₹64.55 Cr, as the split only changes the number of shares, not the total capital value. This proposed split requires shareholder approval through a postal ballot.